» Articles » PMID: 23023295

Structural and Quantitative Evidence for Dynamic Glycome Shift on Production of Induced Pluripotent Stem Cells

Overview
Date 2012 Oct 2
PMID 23023295
Citations 47
Authors
Affiliations
Soon will be listed here.
Abstract

We recently reported that induced pluripotent stem cells (iPSCs) prepared from different human origins acquired similar glycan profiles to one another as well as to human embryonic stem cells. Although the results strongly suggested attainment of specific glycan expressions associated with the acquisition of pluripotency, the detailed glycan structures remained to be elucidated. Here, we perform a quantitative glycome analysis targeting both N- and O-linked glycans derived from 201B7 human iPSCs and human dermal fibroblasts as undifferentiated and differentiated cells, respectively. Overall, the fractions of high mannose-type N-linked glycans were significantly increased upon induction of pluripotency. Moreover, it became evident that the type of linkage of Sia on N-linked glycans was dramatically changed from α-2-3 to α-2-6, and the expression of α-1-2 fucose and type 1 LacNAc structures became clearly apparent, while no such glycan epitopes were detected in fibroblasts. The expression profiles of relevant glycosyltransferase genes were fully consistent with these results. These observations indicate unambiguously the manifestation of a "glycome shift" upon conversion to iPSCs, which may not merely be the result of the initialization of gene expression, but could be involved in a more aggressive manner either in the acquisition or maintenance of the undifferentiated state of iPSCs.

Citing Articles

Total cell N-glycosylation is altered during differentiation of induced pluripotent stem cells to neural stem cells and is disturbed by trisomy 21.

Cindric A, Vuckovic F, Murray A, Klaric T, Alic I, Kristic J BBA Adv. 2025; 7():100137.

PMID: 39845703 PMC: 11751427. DOI: 10.1016/j.bbadva.2024.100137.


Specific sialylation of N-glycans and its novel regulatory mechanism.

Gu J, Isaji T Glycoconj J. 2024; 41(3):175-183.

PMID: 38958800 PMC: 11329402. DOI: 10.1007/s10719-024-10157-8.


Glycan Modifications as Regulators of Stem Cell Fate.

Alghazali R, Nugud A, El-Serafi A Biology (Basel). 2024; 13(2).

PMID: 38392295 PMC: 10886185. DOI: 10.3390/biology13020076.


ST6GAL1 sialyltransferase promotes acinar to ductal metaplasia and pancreatic cancer progression.

Bhalerao N, Chakraborty A, Marciel M, Hwang J, Britain C, Silva A JCI Insight. 2023; 8(19).

PMID: 37643018 PMC: 10619436. DOI: 10.1172/jci.insight.161563.


Reliable -Glycan Analysis-Removal of Frequently Occurring Oligosaccharide Impurities by Enzymatic Degradation.

Burock R, Cajic S, Hennig R, Buettner F, Reichl U, Rapp E Molecules. 2023; 28(4).

PMID: 36838829 PMC: 9967028. DOI: 10.3390/molecules28041843.


References
1.
Schopperle W, DeWolf W . The TRA-1-60 and TRA-1-81 human pluripotent stem cell markers are expressed on podocalyxin in embryonal carcinoma. Stem Cells. 2006; 25(3):723-30. DOI: 10.1634/stemcells.2005-0597. View

2.
An H, Gip P, Kim J, Wu S, Park K, McVaugh C . Extensive determination of glycan heterogeneity reveals an unusual abundance of high mannose glycans in enriched plasma membranes of human embryonic stem cells. Mol Cell Proteomics. 2011; 11(4):M111.010660. PMC: 3322563. DOI: 10.1074/mcp.M111.010660. View

3.
Tokugawa K, Oguri S, Takeuchi M . Large scale preparation of PA-oligosaccharides from glycoproteins using an improved extraction method. Glycoconj J. 1996; 13(1):53-6. View

4.
Tateno H, Toyota M, Saito S, Onuma Y, Ito Y, Hiemori K . Glycome diagnosis of human induced pluripotent stem cells using lectin microarray. J Biol Chem. 2011; 286(23):20345-53. PMC: 3121447. DOI: 10.1074/jbc.M111.231274. View

5.
Becker D, Lowe J . Fucose: biosynthesis and biological function in mammals. Glycobiology. 2003; 13(7):41R-53R. DOI: 10.1093/glycob/cwg054. View